2001
DOI: 10.1016/s0924-8579(01)00314-4
|View full text |Cite
|
Sign up to set email alerts
|

Mupirocin resistance among Malaysian isolates of methicillin-resistant Staphylococcus aureus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
16
0
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 19 publications
2
16
0
1
Order By: Relevance
“…The mupirocin resistance among the S. aureus clinical isolates is very low in many countries (4). In this investigation, all of the S. aureus isolates were sensitive to mupirocin, and similar results have been shown by Mohajeri et al from western Iran (14).…”
Section: Discussionsupporting
confidence: 89%
See 2 more Smart Citations
“…The mupirocin resistance among the S. aureus clinical isolates is very low in many countries (4). In this investigation, all of the S. aureus isolates were sensitive to mupirocin, and similar results have been shown by Mohajeri et al from western Iran (14).…”
Section: Discussionsupporting
confidence: 89%
“…It appears that the carriage of S. aureus in people's noses plays an important role in the epidemiology and pathogenesis of infections caused by S. aureus, and this status accounts for both community-acquired and nosocomial infections, affecting nearly 20% of the population (2). Nowadays, methicillin-resistant S. aureus (MRSA) strains are of concern within healthcare organizations and in the community, and the frequency of these isolates is widely variable from region to region (3,4). The nasal carriage of community-acquired MRSA (CA-MRSA) is associated with a much higher incidence of clinical manifestations in comparison to other S. aureus strains (5).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Em diferentes áreas da Malásia, que têm uma política de uso restrito de mupirocina, observou-se baixa porcentagem de resistência (1,25%) entre 400 MRSA pesquisados (19) .…”
Section: Discussionunclassified
“…Since 1988, Malaysian hospitals have been using mupirocin to treat a wide spectrum of S. aureus skin/wound infections (Rohani et al 2000;Norazah et al 2001). Although reports of mupirocin resistant in MRSA are still sporadic, the number is rising slowly around the globe (Walker et al 2003, Yun et al 2003Norazah et al 2003).…”
Section: Isolatesmentioning
confidence: 99%